Ask AI
PIK3CA Mutation Assays
INAVO120: Evaluating PIK3CA Mutation Assays of Blood and Tissue From Phase III Trial of Palbociclib and Fulvestrant ± Inavolisib for Hormone Receptor–Positive/HER2-Negative ABC

Released: December 17, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 17, 2025